RES Group, Inc.

RES Group, Inc. is a Cambridge, Massachusetts-based company specializing in Quantitative Systems Pharmacology (QSP) modeling for the pharmaceutical drug development sector. The company provides mechanistic QSP modeling services including First-in-Human (FIH) dose projections for Investigational New Drug (IND) applications and toxicity projections for regulatory submissions. These services support early-stage drug development decision-making by translating complex biological systems data into predictive pharmacological models. RES Group has received NIH SBIR funding across multiple years (2008-2018) for projects including BioPath Finder and OpenBio Workbench for sharing mathematical models in drug discovery.